Pyridinium,1,1'-(1,3-propanediyl)bis-, bromide (1:2)

Suppliers

Names

[ CAS No. ]:
14208-07-2

[ Name ]:
Pyridinium,1,1'-(1,3-propanediyl)bis-, bromide (1:2)

[Synonym ]:
Pyridinium,1,1'-trimethylenebis-,dibromide
G.L. 103
P.M. 360

Chemical & Physical Properties

[ Molecular Formula ]:
C13H16BrN2+

[ Molecular Weight ]:
280.18400

[ Exact Mass ]:
279.05000

[ PSA ]:
7.76000

[ Vapour Pressure ]:
0.000145mmHg at 25°C

[ Index of Refraction ]:
1.52

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UU7450000
CHEMICAL NAME :
Pyridinium, 1,1'-trimethylenebis-, dibromide
CAS REGISTRY NUMBER :
14208-07-2
LAST UPDATED :
199012
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C13-H16-N2.2Br
MOLECULAR WEIGHT :
360.13
WISWESSER LINE NOTATION :
T6KJ A3- AT6KJ &E 2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
510 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
RPTOAN Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- Volume(issue)/page/year: 35,243,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
180 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - other changes
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 90,271,1952

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Pyridine
  • 1,3-Dibromopropane

DownStream

  • Hydrogen bromide
  • Pyridine hydrobromide

Related Compounds

  • Calcium, 6-((3-carboxylatopropanoyl)amino)-2-((3-carboxypropanoyl)amino)hexanoate
  • Antimonate(1-), hexachloro-, hydrogen-d, (OC-6-11)-
  • (3R)-2-[[(5R)-3-amino-5-hydroxy-5-(hydroxymethyl)-2-methoxycyclohex-2-en-1-ylidene]amino]-3-hydroxybutanoic acid
  • rel-4-[(1R,3S)-1-Ethyl-1,3-dimethylpentyl]phenol
  • Iron(1+), chloro[rel-dimethyl (1R,2S,4R,5S)-9,9-dihydroxy-3-methyl-2,4-di(2-pyridinyl-kappaN)-7-[(2-pyridinyl-kappaN)methyl]-3,7-diazabicyclo[3.3.1]nonane-1,5-dicarboxylate-kappaN3,kappaN7]-, (OC-6-52)-
  • [(3R,4R,5R,6R)-6-[[(2S,3aS,6R,7aS)-2-[2-(1-carbamimidoyl-2,5-dihydropyrrol-3-yl)ethylcarbamoyl]-1-[(3R)-3-chloro-2-[[(2R)-2-hydroxy-3-phenylpropanoyl]amino]-4-methylpentanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-6-yl]oxy]-4,5-dihydroxyoxan-3-yl] hydrogen sulfate
  • [(2R,3aS,6R,7aS)-1-[(3S)-2-[[(2R)-3-(3-bromo-4-hydroxyphenyl)-2-hydroxypropanoyl]amino]-3-methylpentanoyl]-2-[4-(diaminomethylideneamino)butylcarbamoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-6-yl] hydrogen sulfate
  • Ferrate(2-), [N-[2-[bis[(carboxy-I masculineO)methyl]amino-I masculineN]ethyl]-N-[2-[[(carboxy-I masculineO)methyl](carboxymethyl)amino-I masculineN]ethyl]glycinato(5-)-I masculineN,I masculineO]-, potassium hydrogen (1:1:1)
  • Cuprate(4-), [mu-[[3,3a(2)-[[3,3a(2)-di(hydroxy-kappaO)[1,1a(2)-biphenyl]-4,4a(2)-diyl]bis(2,1-diazenediyl-kappaN1)]bis[5-amino-4-(hydroxy-kappaO)-2,7-naphthalenedisulfonato]](8-)]]di-, sodium hydrogen (1:2:2)
  • Chromate(4-), [5-chloro-2-hydroxy-3-[[[2-hydroxy-5-[2-(4-sulfophenyl)diazenyl]phenyl]methylene]amino]benzenesulfonato(4-)][3-hydroxy-4-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-1-naphthalenesulfonato(3-)]-, sodium (1:4)
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.